185 related articles for article (PubMed ID: 20175949)
1. Experimental studies of pneumococcal meningitis.
Brandt CT
Dan Med Bull; 2010 Jan; 57(1):B4119. PubMed ID: 20175949
[TBL] [Abstract][Full Text] [Related]
2. Blocking of leukocyte accumulation in the cerebrospinal fluid augments bacteremia and increases lethality in experimental pneumococcal meningitis.
Brandt CT; Lundgren JD; Frimodt-Møller N; Christensen T; Benfield T; Espersen F; Hougaard DM; Ostergaard C
J Neuroimmunol; 2005 Sep; 166(1-2):126-31. PubMed ID: 15982752
[TBL] [Abstract][Full Text] [Related]
3. Time course of hearing loss in an animal model of pneumococcal meningitis.
Kesser BW; Hashisaki GT; Spindel JH; Ruth RA; Scheld WM
Otolaryngol Head Neck Surg; 1999 May; 120(5):628-37. PubMed ID: 10229585
[TBL] [Abstract][Full Text] [Related]
4. Differences in survival, brain damage, and cerebrospinal fluid cytokine kinetics due to meningitis caused by 3 different Streptococcus pneumoniae serotypes: evaluation in humans and in 2 experimental models.
Østergaard C; Brandt C; Konradsen HB; Samuelsson S
J Infect Dis; 2004 Oct; 190(7):1212-20. PubMed ID: 15346330
[TBL] [Abstract][Full Text] [Related]
5. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac.
Rappaport JM; Bhatt SM; Burkard RF; Merchant SN; Nadol JB
J Infect Dis; 1999 Jan; 179(1):264-8. PubMed ID: 9841852
[TBL] [Abstract][Full Text] [Related]
6. Systemically (but not intrathecally) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis.
Koedel U; Bernatowicz A; Frei K; Fontana A; Pfister HW
J Immunol; 1996 Dec; 157(11):5185-91. PubMed ID: 8943431
[TBL] [Abstract][Full Text] [Related]
7. Protective role of NF-kappaB1 (p50) in experimental pneumococcal meningitis.
Kastenbauer S; Koedel U; Weih F; Ziegler-Heitbrock L; Pfister HW
Eur J Pharmacol; 2004 Sep; 498(1-3):315-8. PubMed ID: 15364010
[TBL] [Abstract][Full Text] [Related]
8. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase.
Koedel U; Winkler F; Angele B; Fontana A; Pfister HW
J Cereb Blood Flow Metab; 2002 Jan; 22(1):39-49. PubMed ID: 11807392
[TBL] [Abstract][Full Text] [Related]
9. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection.
Østergaard C; Konradsen HB; Samuelsson S
BMC Infect Dis; 2005 Oct; 5():93. PubMed ID: 16253143
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis.
Meli DN; Coimbra RS; Erhart DG; Loquet G; Bellac CL; Täuber MG; Neumann U; Leib SL
Infect Immun; 2006 Jul; 74(7):3890-6. PubMed ID: 16790761
[TBL] [Abstract][Full Text] [Related]
12. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis.
Paul R; Koedel U; Winkler F; Kieseier BC; Fontana A; Kopf M; Hartung HP; Pfister HW
Brain; 2003 Aug; 126(Pt 8):1873-82. PubMed ID: 12821529
[TBL] [Abstract][Full Text] [Related]
13. Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis.
Kastenbauer S; Koedel U; Pfister HW
J Infect Dis; 1999 Oct; 180(4):1164-70. PubMed ID: 10479144
[TBL] [Abstract][Full Text] [Related]
14. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.
Sellner J; Leib SL
Neurobiol Dis; 2006 Mar; 21(3):647-56. PubMed ID: 16257222
[TBL] [Abstract][Full Text] [Related]
15. Method for inducing experimental pneumococcal meningitis in outbred mice.
Chiavolini D; Tripodi S; Parigi R; Oggioni MR; Blasi E; Cintorino M; Pozzi G; Ricci S
BMC Microbiol; 2004 Sep; 4():36. PubMed ID: 15385055
[TBL] [Abstract][Full Text] [Related]
16. Effects of clinically used antioxidants in experimental pneumococcal meningitis.
Auer M; Pfister LA; Leppert D; Täuber MG; Leib SL
J Infect Dis; 2000 Jul; 182(1):347-50. PubMed ID: 10882622
[TBL] [Abstract][Full Text] [Related]
17. Pneumococcal Meningitis Induces Hearing Loss and Cochlear Ossification Modulated by Chemokine Receptors CX3CR1 and CCR2.
Hirose K; Li SZ; Gill R; Hartsock J
J Assoc Res Otolaryngol; 2024 Apr; 25(2):179-199. PubMed ID: 38472515
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine kinase inhibition reduces inflammation in the acute stage of experimental pneumococcal meningitis.
Angstwurm K; Hanisch UK; Gassemi T; Bille MB; Prinz M; Dirnagl U; Kettenmann H; Weber JR
Infect Immun; 2004 Jun; 72(6):3294-8. PubMed ID: 15155632
[TBL] [Abstract][Full Text] [Related]
19. Effect of experimental pneumococcal meningitis on respiration and circulation in the rabbit.
Sears MR; O'Donoghue JM; Fisher HK; Beaty HN
J Clin Invest; 1974 Jul; 54(1):18-23. PubMed ID: 4152001
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared spectroscopy in experimental pneumococcal meningitis in the rabbit: cerebral hemodynamics and metabolism.
Tureen J; Liu Q; Chow L
Pediatr Res; 1996 Nov; 40(5):759-63. PubMed ID: 8910942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
